FDA inspection
Raptim Research Pvt. Ltd.: FDA inspection ending Jul 25, 2025
FDA inspection 1281109 · Navi Mumbai
Key facts
| Inspection ID | 1281109 |
|---|---|
| Firm | Raptim Research Pvt. Ltd. |
| FEI number | 3007267856 |
| Address | A - 239/A - 242 |
| City | Navi Mumbai |
| Fiscal year | 2025 |
| Inspection end date | Jul 25, 2025 |
| Project area | Bioresearch Monitoring: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data